Central actions of dopa and dopamine
Sourkes, T.L.
Revue Canadienne de Biologie 31(Suppl): 153-168
1972
ISSN/ISBN: 0035-0915 PMID: 4403289 Document Number: 46264
Document emailed within 1 workday
Related Documents
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556Lun, A.; Szuecz, L.; Gross, J.; Horvath, G.; Nagy, I. 1989: Effect of mild postnatal hypoxia and L-dopa administration on dopamine concentration in striata of the newborn rat and long term sequelae on dopamine turnover Biomedica Biochimica Acta 48(2-3): S231-S236
Zarifian, E. 1979: Dopa and dopamine agonists in depression L'Encephale 5(5 Suppl): 665-670
Hefti, F.; Melamed, E.; Wurtman, R.J. 1981: The site of dopamine formation in rat striatum after L-dopa administration Journal of Pharmacology and Experimental Therapeutics 217(1): 189-197
Acton, G. 1988: Effects of D-5-hydroxytryptophan and D-DOPA on binding at serotonin and dopamine receptors Research Communications in Chemical Pathology and Pharmacology 60(1): 129-132
Borisova, N.V.; Kaplun, A.P.; Bogomolov, O.V.; Grigor'ev, V.B.; Iurasov, V.V.; Nikushkin, E.V.; Kryzhanovskiĭ, G.N.; Shvets, V.I. 1996: Physico-chemical properties of liposome forms of L-3,4-dihydroxyphenylalanine (DOPA) and dopamine Bioorganicheskaia Khimiia 22(10-11): 846-851
Valori, C.; Brunori, C.A.; Renzini, V.; Porcellati, C. 1971: Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine Annali Dell'istituto Superiore di Sanita 7(2): 414-421
Borisova, N.V.; Kriukov, V.I.; Kaplun, A.P.; Shvets, V.I. 1998: Physico-chemical properties of borate derivatives of DOPA, dopamine, and their liposome forms Bioorganicheskaia Khimiia 24(11): 848-855
Beramendi, V.; Alpert, M.; Guimón, J.; Friedhoff, A.; Gutiérrez, M. 1980: Controlled study of L-dopa in schizophrenia with reference to the theory of hypersensitivity of dopamine receptors Archivos de Neurobiologia 43(2): 107-124
Gershteĭn, L.M.; Sergutina, A.V.; Titov, S.A.; Chebotareva, T.L. 1990: Neurochemical aspects of the cortical-subcortical interrelations after activation of the dopamine system with L-dopa Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(10): 68-71
Streifler, M.; Vardi, Y.; Kesten, M.; Oberman, Z.; Herzberg, M. 1972: Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease Israel Journal of Medical Sciences 81(5): 597-601
Buscaino, G.A.; Sori, A.; Campanella, G. 1972: Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa Revue Neurologique (Paris) 127(2): 301-302
Syvomiatnikova, N.V.; Mel'nikova, T.O.; Goncharova, V.A. 1972: Dopamine and dopa as indices of reserve potential of the sympatho-adrenal system in pulmonary heart Terapevticheskii Arkhiv 44(5): 94-96
Markovska, V.; Georgiev, V.; Ankov, V. 1979: Influence of x-ray irradiation on the effects of apomorphine and L-dopa with respect to the dopamine level in rat brain and corpus striatum Acta Physiologica et Pharmacologica Bulgarica 5(4): 27-34
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Pizzolato, G.; Cagnin, A.; Rossato, A.; Chierichetti, F.; Fabbri, M.; Dam, M.; Ferlin, G.; Battistin, L. 1996: Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. a [123I]IBZM SPET study Advances in Neurology 69: 467-473
Schmidt, C.J.; Taylor, V.L.; Abbate, G.M.; Nieduzak, T.R. 1991: 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa Journal of Pharmacology and Experimental Therapeutics 256(1): 230-235
Verma, A.; Kulkarni, S.K. 1991: Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice Indian Journal of Experimental Biology 29(2): 123-126
Youngren, K.D.; Daly, D.A.; Moghaddam, B. 1993: Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens Journal of Pharmacology and Experimental Therapeutics 264(1): 289-293
Porsius, A.J.; Van Zwieten, P.A. 1978: The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application Arzneimittel-Forschung 28(9): 1628-1631